Open access
Open access
Powered by Google Translator Translator

Internal Medicine

Study Estimates Impact of Social Distancing on Reducing Spread of COVID-19

25 Mar, 2020 | 02:51h | UTC

Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study – The Lancet Infectious Diseases

Commentaries: Singapore modelling study estimates impact of physical distancing on reducing spread of COVID-19 – The Lancet AND Scientific and ethical basis for social-distancing interventions against COVID-19 – The Lancet Infectious Diseases AND Study: Social distancing might reduce COVID-19 spread by as much as 99% – UPI

 


Study: Effect of Gastrointestinal Symptoms on Patients Infected with COVID-19

25 Mar, 2020 | 02:36h | UTC

Effect of gastrointestinal symptoms on patients infected with COVID-19 – Gastroenterology (PDF)

See also: COVID-19: Updates for Gastroenterologists

 


New WHO Recommendations to Prevent Tuberculosis

25 Mar, 2020 | 02:55h | UTC

WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment – World Health Organization (free)

News Release: New WHO recommendations to prevent tuberculosis aim to save millions of lives – World Health Organization (free)

See also: Handbook (free)

Commentaries: Don’t forget chronic lung and immune conditions during covid-19, says WHO – The BMJ (free) AND As COVID-19 rages, WHO calls for more efforts to prevent TB – CIDRAP (free)

 


Review: Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease

25 Mar, 2020 | 02:43h | UTC

Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease – Circulation

See also: COVID-19: Updates for Cardiologists

 


AHA: Interim Guidance to Reduce COVID-19 Transmission During Resuscitation Care

25 Mar, 2020 | 02:47h | UTC

Interim Guidance for Healthcare Providers during COVID-19 Outbreak – American Heart Association (free PDF)

News Release: Interim guidance to reduce COVID-19 transmission during resuscitation care – American Heart Association (free)

Related: Interim Guidance for Emergency Medical Services (EMS) Systems and 911 Public Safety Answering Points (PSAPs) for COVID-19 in the United States – Centers for Disease Control and Prevention (free)

See also: COVID-19: Updates for Cardiologists

 


Review: Nonalcoholic Steatohepatitis

25 Mar, 2020 | 02:00h | UTC

Nonalcoholic Steatohepatitis: A Review – JAMA (free for a limited period)

Related Podcast: Nonalcoholic Steatohepatitis: The Primary Care Perspective – JAMA (free)

 


Pill Splitting: Making the Most of Meds in a Time of Need

25 Mar, 2020 | 02:29h | UTC

[Special Edition: March 2020] Pill splitting: Making the most of meds in a time of need – Therapeutics Initiative (free)

 


Cohort Study: Risk of Colorectal Cancer Incidence and Mortality after Polypectomy

25 Mar, 2020 | 01:57h | UTC

Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study – The Lancet Gastroenterology & Hepatology (free)

Commentaries: Polyps and Colorectal Cancer risk – Karolinska Institutet (free) AND Risk of colorectal cancer incidence and mortality after polypectomy – ESMO (free)

 


Chloroquine for COVID-19: Cutting Through the Hype

24 Mar, 2020 | 11:32h | UTC

Chloroquine for COVID-19: Cutting Through the Hype – The Scientist

See also: Statistical review of Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial – Zenodo

 


[Preprint] Incidence, Clinical Characteristics and Prognostic Factor of Patients with COVID-19: A Systematic Review and Meta-analysis

24 Mar, 2020 | 11:37h | UTC

Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis – medRxiv (free PDF)

Commentary: Study Calculates Just How Much Age, Medical Conditions Raise Odds Of Severe COVID-19 – NPR (free)

 


Fair Allocation of Scarce Medical Resources in the Time of Covid-19

24 Mar, 2020 | 11:42h | UTC

Fair Allocation of Scarce Medical Resources in the Time of Covid-19 – New England Journal of Medicine

Commentary: Life, or death? Experts guide pandemic medical equipment decisions – CIDRAP

Related Perspective: The Toughest Triage — Allocating Ventilators in a Pandemic – New England Journal of Medicine

 


FDA Recommendations for Conserving Medical Supplies

24 Mar, 2020 | 11:23h | UTC

See also: Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention (free)

 


Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019

23 Mar, 2020 | 01:37h | UTC

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) – Intensive Care Medicine (free PDF)

Infographics: The Surviving Sepsis Campaign Rapid Guidelines on the Management of Critically Ill Adults with COVID-19 (free)

See also: COVID-19: Updates for Critical Care and Emergency Physicians (free resources)

 


NICE COVID-19 Rapid Guideline: Critical Care

23 Mar, 2020 | 01:32h | UTC

COVID-19 rapid guideline: critical care – National Institute for Health and Care Excellence (NICE)

See also: COVID-19: Updates for Critical Care and Emergency Physicians (free resources)

 


COVID-19: Updates for Critical Care and Emergency Physicians

25 May, 2020 | 00:01h | UTC

Guidelines:

Podcasts:

Videos:

Selected Articles:

“This pandemic has changed the risk-benefit balance for CPR: from “there is no harm in trying” to “there is little benefit to the patient, and potentially significant harm to staff.””

News & Perspectives:

COVID-19 Critical Care: This page will be updated as often as necessary and will be fixed in the right column on our homepage.

 


CDC Guidance: Preparing Long-term Care Facilities and Nursing Homes for COVID-19

24 Mar, 2020 | 11:28h | UTC

Preparing for COVID-19: Long-term Care Facilities, Nursing Homes – Centers for Disease Control and Prevention

Related Guideline: Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19 – World Health Organization (PDF)

Related Article: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report

Related Perspective: The Coronavirus’s Rampage Through a Suburban Nursing – The New York Times

 


CEBM Estimates Infection Rate Fatality (IFR) of COVID-19 at 0,20%

23 Mar, 2020 | 01:16h | UTC

Global Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)

 


[Preprint] Randomized Trial: Favipiravir vs. Arbidol for COVID-19

23 Mar, 2020 | 01:18h | UTC

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial – medRxiv

 


Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19

23 Mar, 2020 | 01:34h | UTC

Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19 – World Health Organization (PDF)

Related Study: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report (free)

“Introduction of COVID-19 into a long-term residential care facility in Washington resulted in cases among 81 residents, 34 staff members, and 14 visitors; 23 persons died” (from CDC)

 


Loss of Smell and Taste Could be a Sign of COVID-19

23 Mar, 2020 | 01:11h | UTC

Position Statement: Loss of sense of smell as marker of COVID-19 infection – ENT-UK

See also: There’s An Unexpected Loss Of Smell And Taste In Coronavirus Patients – Forbes  AND If you’ve lost your sense of smell or taste, you could be a ‘hidden carrier’ of the coronavirus – Business Insider

 


IDSA Statement: COVID-19 Prioritization of Diagnostic Testing

20 Mar, 2020 | 11:01h | UTC

COVID-19 Prioritization of Diagnostic Testing – Infectious Diseases Society of America (free PDF)

Summary: IDSA Statement On COVID-19 Testing Recommendations – Infectious Diseases Society of America (free)

 


Editorial by John P.A. Ioannidis: COVID-19: The Harms of Exaggerated Information and Non‐evidence‐based Measures

23 Mar, 2020 | 01:08h | UTC

Coronavirus disease 2019: the harms of exaggerated information and non‐evidence‐based measures – European Journal of Clinical Investigation (free PDF)

Related Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT (free)

Rebuttal 1: We know enough now to act decisively against Covid-19. Social distancing is a good place to start – STAT (free)

Rebuttal 2: A Rebuttal to “A Fiasco in the Making?” – Hilda Bastian (Free)

 


New Preliminary Studies with Hydroxychloroquine:

20 Mar, 2020 | 10:57h | UTC

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial – International Journal of Antimicrobial Agents (free PDF)

This was an open-label study with only 42 patients without patient-relevant endpoints. The 6 patients that received Hydroxychloroquine + Azithromycin achieved more efficient virus elimination than control patients.

New in Vitro Study: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro – Cell Discovery (free)

Related Articles: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – Clinical Infectious Diseases (free PDF) AND New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? – International Journal of Antimicrobial Agents (free) AND A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 – Journal of Critical Care (free) AND Of chloroquine and COVID-19 – Antiviral Research (free)

 


Consensus Guideline: Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus Aureus Infections

20 Mar, 2020 | 11:07h | UTC

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists – American Journal of Health-System Pharmacy (free)

 


CDC Guideline: Strategies for Optimizing the Supply of Facemasks

20 Mar, 2020 | 11:03h | UTC

Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.